Ana Damaso
Introduction: metabolic syndrome is a constellation of altered parameters that coexist with obesity increasing risks for cardiovascular disease.
Objective: To evaluate 1) the effects of the clinical multicomponent therapy in the prevalence of metabolic syndrome; and 2) if the leptin and adiponectin can modulate its response in women with obesity.
Methods: Interdisciplinary therapy consisted of follow-up with an endocrinologist, nutritionist, and exercise physiologist, associated with health education by web-based weekly videos about exercise and nutrition to promote lifestyle changes (# 12semanas®) and support through Facebook®, Instagram® and WhatsApp®. This study can be approved by the Research Ethics Committee. Women with obesity (n = 32), aged 31.06 ± 4.70 years and BMI of 34.01 ± 4.00 kg/m² were selected. Body composition by electric bioimpedance and adiponectin, leptin by ELISA were performed. The metabolic syndrome screening was made by IDF criteria.
Results: At the beginning of therapy 21.8% of women with obesity present metabolic syndrome (MS) diagnosis wich was reduced to 3%. In the delta comparison, MS group presented higher values for body weight, waist circumference, body fat, total cholesterol, and reduced HDL-c. Improvements were finding in body composition and lipid profile in both analysed groups. In the MS group it were observed a reduction in the leptin concentration. Delta comparison finding a positive correlation between leptin/adiponectin ratio with waist circumference and HOMA-AD.
Conclusion: Clinical approach associated with health education was effective in reducing the MS prevalence mediated by leptin and adiponectin avoid the development of cardiovascular disease in women with obesity.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu